439 related articles for article (PubMed ID: 32069085)
1. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
[No Abstract] [Full Text] [Related]
2. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
3. Pleural fluid pH in parapneumonic effusions.
Potts DE; Levin DC; Sahn SA
Chest; 1976 Sep; 70(03):328-31. PubMed ID: 8283
[TBL] [Abstract][Full Text] [Related]
4. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of suPAR in differentiating noncardiac pleural effusions from cardiac pleural effusions.
Ozsu S; Oztuna F; Mentese A; Abul Y; Ozlu T
Clin Respir J; 2016 Jan; 10(1):61-6. PubMed ID: 25043397
[TBL] [Abstract][Full Text] [Related]
6. The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions.
Varsamas C; Kalkanis A; Gourgoulianis KI; Malli F
Can Respir J; 2020; 2020():1283590. PubMed ID: 33082889
[TBL] [Abstract][Full Text] [Related]
7. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
8. Pleural effusions caused by infection.
Varkey B
Postgrad Med; 1986 Oct; 80(5):213-6, 219, 222-3. PubMed ID: 3763525
[TBL] [Abstract][Full Text] [Related]
9. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
Maskell NA; Gleeson FV; Darby M; Davies RJ
Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
[TBL] [Abstract][Full Text] [Related]
10. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions.
Henke CA; Leatherman JW
Am Rev Respir Dis; 1992 Mar; 145(3):680-4. PubMed ID: 1546851
[TBL] [Abstract][Full Text] [Related]
11. [From pneumonic infiltration to parapneumonic effusion--from effusion to pleural empyema: internal medicine aspects of parapneumonic effusion development and pleural empyema].
Domej W; Wenisch C; Demel U; Tilz GP
Wien Med Wochenschr; 2003; 153(15-16):349-53. PubMed ID: 13677257
[TBL] [Abstract][Full Text] [Related]
12. Parapneumonic effusions.
Light RW; Girard WM; Jenkinson SG; George RB
Am J Med; 1980 Oct; 69(4):507-12. PubMed ID: 7424940
[TBL] [Abstract][Full Text] [Related]
13. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
15. Parapneumonic pleural effusion and empyema.
Koegelenberg CF; Diacon AH; Bolliger CT
Respiration; 2008; 75(3):241-50. PubMed ID: 18367849
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the management of complicated pleural effusion: From intrapleural agents to surgery.
Sorino C; Mondoni M; Lococo F; Marchetti G; Feller-Kopman D
Respir Med; 2022 Jan; 191():106706. PubMed ID: 34896966
[TBL] [Abstract][Full Text] [Related]
17. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R
Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
[TBL] [Abstract][Full Text] [Related]
18. Pleural fluid pH: diagnostic, therapeutic, and prognostic value.
Houston MC
Am J Surg; 1987 Sep; 154(3):333-7. PubMed ID: 3307471
[TBL] [Abstract][Full Text] [Related]
19. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
20. Parapneumonic effusions and empyema.
Light RW
Proc Am Thorac Soc; 2006; 3(1):75-80. PubMed ID: 16493154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
